Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • REGENERON PHARMACEUTICALS Earnings Analysis

  • Earnings Summary: REGN

    EPS (TTM): -0.79 Current P/E Ratio: -24.43038
    Last Quarter's Earnings: -0.01 Current Quarter Estimate: -0.302
    Last Fiscal Year Earnings: -1.05 Next Fiscal Year Estimate: -1.143
    Analyst Consensus: Buy Dividend Rate: 0.00
    Last Dividend: 0.00
  • Reported Quarters: REGN

    Quarterly EPS millions
  • Seasonal Performance: REGN